S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation

Clinical trial NCT00244426 · COMPLETED

Trial details

NCT number: NCT00244426
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2000-12-01
Primary completion: 2008-04-01
Enrollment: 1372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.